Russell Van Dyke, MD

Professor of Clinical Pediatrics

Section Chief, Pediatrics Infectious Diseases
Phone
504-988-2570
Office Address
1440 Canal Street, Rm. 1600, New Orleans, LA 70112
School of Medicine
Department
Pediatrics
CV

Education & Affiliations

M.D., Medical College of Wisconsin, Milwaukee, Wisconsin.
Pediatric Residency, University of California, San Diego San Diego, California.
Fellowship in Pediatric Infectious Diseases University of California, San Diego, San Diego, California. Laboratory of Dr. James Connor

Areas of Expertise

Pediatrics Infectious Diseases

Biography

Research

• Antiviral chemotherapy and antiviral sensitivity testing.
• Rapid viral diagnosis.
• Immunologic response to respiratory syncytial virus infection.
• The development of human monoclonal antibodies to respiratory syncytial virus and their
use in prevention and modification of infection.
• The epidemiology, diagnosis, prevention, and treatment of human immunodeficiency virus
infections in children. The pathogenesis of the vertical transmission of HIV.
• The epidemiology and prevention of HTLV-1 and HTLV-II infections.
• The epidemiology and outcomes of children and youth with perinatal HIV infection

Contributions

  1. Shearer WT, Jacobson DL, Yu W, Siberry GK, Purswani M, Siminski S, Butler L, Leister E, Scott G, Van Dyke RB, Yogev R, Paul ME, Puga A, Colin AA, and Kattan M for the Pediatric 29 Russell B. Van Dyke March 15, 2017 HIV/AIDS Cohort Study. Long-Term Pulmonary Complications in Perinatally HIV-Infected Youth. J Allergy Clin Immunol 2017; In-press.
  2. Neilan AM, Karalius B, Patel K, Van Dyke RB, Abzug MJ, Agwu AL, Williams PL, Purswani M,
    Kacanek D, Oleske JM, Burchett SK, Wiznia A, Chernoff M, Seage GR III, and Ciaranello
    AL,for the Pediatric HIV/AIDS Cohort Study and the International Maternal Adolescent and
    Pediatric AIDS Clinical Trials Network. Greater risk for viremia, immunosuppression,
    serious clinical events, and mortality with increasing age: the US perinatal HIV
    epidemic in its adolescence. JAMA Peds 2017; In-press.
  3. Lewis-de los Angeles CP, Williams PL, Huo Y, Wang SD, Uban KA, Herting MM, Malee K,
    Yogev R, Csernansky JG, Nichols S, Van Dyke RB, Sowell ER, and Wang L for the Pediatric
    HIV/AIDS Cohort Study and the Pediatric, Imaging, Neurocognition, and Genetics Study.
    Lower total and regional grey matter brain volumes in youth with perinatally-acquired
    HIV infection: associations with HIV disease severity, substance use, and cognition.
    Brain. Behav. Immun 2017. e-pub ahead of print. PMCID: PMC in process.
  4. Uprety P, Patel K, Karalius B, Ziemniak C, Chen HY, Brummel S, Siminski S, Van Dyke RB,
    Seage GR III and Persaud D for the Pediatric HIV/AIDS Cohort Study. HIV-1 DNA Decay
    Dynamics with Early, Long- term Virologic Control of Perinatal Infection. Clin Infect Dis
    2016; In-press.
  5. Takemoto JK, Miller TL, Wang J, Jacobson DL, Geffner ME, Van Dyke RB, and Gerschenson
    M for the Pediatric HIV/AIDS Cohort Study. Insulin Resistance in HIV-Infected Youth is
    associated with decreased mitochondrial respiration. AIDS 2016. 31(1):15-23. PMCID:
    PMC 5136181
  6. Lewis-de los Angeles CP, Alpert KI, Williams PL, Malee K, Huo Y, Csernansky JG, Yogev R,
    Van Dyke RB, Sowell ER, and Wang L for the Pediatric HIV/AIDS Cohort Study (PHACS).
    Deformed subcortical structures are related to HIV disease severity in youth with
    perinatally-acquired HIV infection. J Pediatric Infect Dis Soc 2016; 5(suppl 1):S6-S14;
    PMCID: PMC5181545.
  7. Spector SA, Brummel SS, Nievergelt CM, Maihofer AX, Singh KK, Purswani M, Williams PL,
    Hazra R, Van Dyke RB, and Seage GRIII for the Pediatric HIV/AIDS Cohort Study.
    Genetically Determined Ancestry is More Informative than Self-Reported Race in HIVInfected
    and -Exposed Children. Medicine 2016; In- press
  8. Moscicki A-B, Yao T-J, Ryder MI, Russell JS, Dominy SS, Patel K, McKenna M, Van Dyke RB,
    Seage GRIII, Hazra R, and Shiboski C for the Pediatric HIV/AIDS Cohort Study. The Burden
    of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected Youth.
    PLoS One 2016; 11(6); PMCID: PMC4907464.
  9. Van Dyke RB, Chadwick G Ellen, Hazra R, Williams PL, and Seage GR III for the Pediatric
    HIV/AIDS Cohort Study. The PHACS SMARTT study: assessment of the safety of in utero
    exposure to antiretroviral drugs. Frontiers in Immunology 2016; May 23; 7:199. PMID:
    27242802.
  10. Tassiopoulos K, Patel K, Alperen J, Kacanek D, Ellis A, Berman C, Allison SM, Hazra R, Barr
    E, Cantos K, Siminski S, Massagli M, Bauermeister J, Siddiqui DQ, Puga A, Van Dyke RB,
    and Seage GR III for the Pediatric HIV/AIDS Cohort Study. Following young people with
    perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP
    Up, a prospective cohort study. BMJ Open 2016; In-press